[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"Carcinoma",4,3,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04897321","B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)",[12],"Phase 1","RECRUITING","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.511090Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06915727","An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors",[20],"Phase 3","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:27.987617Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT00349830","Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy",[],"2026-08-26T02:19:31.671303Z","2026-05-13T02:55:06.034511Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT00923026","Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:03.788292Z","2026-06-16T05:54:07.944666Z",[],[]]